Targeting EZH2 for glioma therapy with a novel nanoparticle–siRNA complex

摘要

BackgroundFor the past few years, gene-therapy has recently shown considerable clinical benefit in cancer therapy, and the applications of gene therapies in cancer treatments continue to increase perennially. EZH2, an ideal candidate for tumor gene therapy, plays an important role in the tumorigenesis.